Related Experiment Video
Updated: May 16, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Negative regulation of ERα by a novel protein CAC1 through association with histone demethylase LSD1
JuHyun Kim1, Ui-Hyun Park, MinO Moon
1Department of Molecular Biology, BK21 Graduate Program, Dankook University, Yongin-si, Gyeonggi-do 448-701, Republic of Korea.
Abstract:
ERα, a critical transcriptional factor for breast cancer proliferation, is regulated by a complex binding repertoire that includes coactivators and corepressors. Here, we identified a novel class of ERα coregulator called CAC1. The CoRNR box of CAC1 was required for the binding to and inactivation of ERα. CAC1 also associated with histone demethylase LSD1 and suppressed LSD1-enhanced ERα activity. CAC1 impaired recruitment of ERα and LSD1 to the ERα-responsive promoter, leading to greater H3K9me3 accumulation. This effect was reversed by CAC1 depletion. Finally, CAC1 increased paclitaxel-induced cell death in ERα-positive MCF7 cells, which are paclitaxel-resistant. Overall, our study provides the first evidence that CAC1, associated with LSD1, functions as an ERα corepressor, implicating a potential antitumor target in ERα-positive breast cancer.
Insights
Researchers discovered CAC1, a novel corepressor for estrogen receptor alpha (ERα). CAC1, working with LSD1, inhibits ERα activity and enhances chemotherapy in ERα-positive breast cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Estrogen receptor alpha (ERα) is a key driver of breast cancer proliferation.
- ERα activity is modulated by coactivators and corepressors.
Purpose of the Study:
- To identify novel ERα coregulators.
- To investigate the function of CAC1 in ERα regulation and breast cancer.
Main Methods:
- Co-immunoprecipitation assays to study protein interactions.
- Chromatin immunoprecipitation (ChIP) to assess promoter recruitment and histone modifications.
- Cell viability assays to evaluate drug response.
Main Results:
- CAC1 binds to ERα via its CoRNR box, inhibiting ERα activity.
- CAC1 interacts with histone demethylase LSD1, suppressing its pro-tumorigenic effects.
- CAC1 depletion reverses the observed effects, indicating its crucial role.
- CAC1 enhances paclitaxel-induced cell death in paclitaxel-resistant MCF7 cells.
Conclusions:
- CAC1 functions as a novel ERα corepressor, collaborating with LSD1.
- CAC1 represents a potential therapeutic target for ERα-positive breast cancer.
More Related Videos
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Related Concept Videos
Master Transcription Regulators
Regulation of Nuclear Protein Sorting
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Co-activators and Co-repressors